Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the target of a large decline in short interest in May. As of May 15th, there was short interest totalling 5,300 shares, a decline of 50.5% from the April 30th total of 10,700 shares. Currently, 0.9% of the company’s stock are short sold. Based on an […]
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price objective hoisted by equities research analysts at UBS Group from $174.00 to $193.00 in a report released on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. UBS Group’s target price points to a potential upside of 43.37% from the company’s […]
Wedbush reiterated their outperform rating on shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) in a research note published on Wednesday morning, Benzinga reports. Wedbush currently has a $152.00 target price on the stock. NBIX has been the topic of a number of other research reports. Canaccord Genuity Group lifted their price target on shares […]
Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) have been assigned an average recommendation of “Buy” from the six analysts that are currently covering the firm, Marketbeat reports. Six analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have covered the stock in the last […]
8Vc Gp I LLC bought a new position in shares of Senti Biosciences, Inc. (NASDAQ:SNTI – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 2,537,558 shares of the company’s stock, valued at approximately $1,675,000. Senti Biosciences makes up about 1.7% of 8Vc Gp […]